Genovesi, S.; Moro, R.; Vignoli, B.; De Felice, D.; Canossa, M.; Montironi, R.; Carbone, F.G.; Barbareschi, M.; Lunardi, A.; Alaimo, A.
Trpm8 Expression in Human and Mouse Castration Resistant Prostate Adenocarcinoma Paves the Way for the Preclinical Development of TRPM8-Based Targeted Therapies. Biomolecules 2022, 12, 193.
https://doi.org/10.3390/biom12020193
AMA Style
Genovesi S, Moro R, Vignoli B, De Felice D, Canossa M, Montironi R, Carbone FG, Barbareschi M, Lunardi A, Alaimo A.
Trpm8 Expression in Human and Mouse Castration Resistant Prostate Adenocarcinoma Paves the Way for the Preclinical Development of TRPM8-Based Targeted Therapies. Biomolecules. 2022; 12(2):193.
https://doi.org/10.3390/biom12020193
Chicago/Turabian Style
Genovesi, Sacha, Riccardo Moro, Beatrice Vignoli, Dario De Felice, Marco Canossa, Rodolfo Montironi, Francesco Giuseppe Carbone, Mattia Barbareschi, Andrea Lunardi, and Alessandro Alaimo.
2022. "Trpm8 Expression in Human and Mouse Castration Resistant Prostate Adenocarcinoma Paves the Way for the Preclinical Development of TRPM8-Based Targeted Therapies" Biomolecules 12, no. 2: 193.
https://doi.org/10.3390/biom12020193
APA Style
Genovesi, S., Moro, R., Vignoli, B., De Felice, D., Canossa, M., Montironi, R., Carbone, F. G., Barbareschi, M., Lunardi, A., & Alaimo, A.
(2022). Trpm8 Expression in Human and Mouse Castration Resistant Prostate Adenocarcinoma Paves the Way for the Preclinical Development of TRPM8-Based Targeted Therapies. Biomolecules, 12(2), 193.
https://doi.org/10.3390/biom12020193